Literature DB >> 11360248

Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS.

E B Quinlivan1, R X Wang, P W Stewart, C Kolmoltri, N Regamey, P Erb, P L Vernazza.   

Abstract

The relationship between viral infection with Kaposi sarcoma-associated herpesvirus (KSHV) and the onset of Kaposi sarcoma (KS) in AIDS patients is incompletely understood. This study investigates the use of three serological assays to predict the development of KS in HIV-positive patients. Serially collected serum samples from 36 patients with KS and matched controls in the Swiss HIV Cohort Study (SHCS) were analyzed in a case control study. Three serologic assays to detect antibodies against KSHV (nuclear and membrane antigen immunofluorescence assay, N-IFA, M-IFA and ORF 65.2 ELISA) were used to determine the predictive value of KSHV-seropositivity. Serial samples from the cases were also analyzed to determine longitudinal patterns of seroreactivity and identify cases of seroconversion. Assay sensitivity for detection of KSHV antibodies was highest for M-IFA (83%), followed by N-IFA (74%) and 65.2 ELISA (52%). At the time of initial serum sampling (median 4.7 years before KS), only the N-IFA distinguished case and control sera (61% vs. 32%) and no assay was clearly predictive of subsequent onset of clinical KS. Moreover, an unexpectedly high rate of reversions to seronegativity were observed by N-IFA (27/33) as well as by 65.2 ELISA (11/26) in the longitudinal analysis. Analysis of the ORF65.2 ELISA index indicated that these reversions before the clinical onset of KS were associated with antibody levels that frequently hovered around the level of detectability. A marked increase in ORF 65.2 antibody titer occurred in a third of the patients at the time of KS diagnosis. Only two seroconversions were documented. KSHV infection within the SHCS is likely to have preceded HIV infection. KSHV infection alone is not highly predictive of KS development in this cohort of HIV-infected homosexual men as compared with matched controls. Three KSHV serologic assays, though sensitive at the time of clinical KS are inconsistently positive before the development of AIDS-related KS. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11360248     DOI: 10.1002/jmv.1031

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

Review 1.  Serodiagnosis for tumor viruses.

Authors:  Brian J Morrison; Nazzarena Labo; Wendell J Miley; Denise Whitby
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

Review 2.  Human herpesviruses 6, 7, and 8 from a dermatologic perspective.

Authors:  Michael M Wolz; Gabriel F Sciallis; Mark R Pittelkow
Journal:  Mayo Clin Proc       Date:  2012-07-21       Impact factor: 7.616

3.  Relationships Between Maternal Antibody Responses and Early Childhood Infection With Kaposi Sarcoma-Associated Herpesvirus.

Authors:  Lisa K Poppe; Chipepo Kankasa; Charles Wood; John T West
Journal:  J Infect Dis       Date:  2020-10-13       Impact factor: 5.226

Review 4.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

5.  Human herpesvirus 8 seroprevalence among Tobago women and the role of sexual lifestyle behavior.

Authors:  Alicia C McDonald; Camille C Ragin; Frank J Jenkins; Joel Weissfeld; John Wilson; Victor W Wheeler; Jaquie B Wilson; Clareann H Bunker; Emanuela Taioli
Journal:  J Med Virol       Date:  2009-02       Impact factor: 2.327

6.  Development of an immunofluorescence assay using recombinant proteins expressed in insect cells to screen and confirm presence of human herpesvirus 8-specific antibodies.

Authors:  Veenu Minhas; Lynsey N Crosby; Kay L Crabtree; Saul Phiri; Tendai J M'soka; Chipepo Kankasa; William J Harrington; Charles D Mitchell; Charles Wood
Journal:  Clin Vaccine Immunol       Date:  2008-05-28

7.  Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area.

Authors:  Veenu Minhas; Kay L Crabtree; Ann Chao; Tendai J M'soka; Chipepo Kankasa; Marc Bulterys; Charles D Mitchell; Charles Wood
Journal:  Am J Epidemiol       Date:  2008-05-30       Impact factor: 4.897

8.  Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome.

Authors:  Nazzarena Labo; Wendell Miley; Vickie Marshall; William Gillette; Dominic Esposito; Matthew Bess; Alexandra Turano; Thomas Uldrick; Mark N Polizzotto; Kathleen M Wyvill; Rachel Bagni; Robert Yarchoan; Denise Whitby
Journal:  PLoS Pathog       Date:  2014-03-27       Impact factor: 6.823

9.  Malaria Is Associated With Kaposi Sarcoma-Associated Herpesvirus Seroconversion in a Cohort of Western Kenyan Children.

Authors:  Katherine R Sabourin; Ibrahim Daud; Sidney Ogolla; Nazzarena Labo; Wendell Miley; Molly Lamb; Robert Newton; Denise Whitby; Rosemary Rochford
Journal:  J Infect Dis       Date:  2021-07-15       Impact factor: 5.226

10.  Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: a nested case-control study.

Authors:  Katie Wakeham; W Thomas Johnston; Angela Nalwoga; Emily L Webb; Billy N Mayanja; Wendell Miley; Alison M Elliott; Denise Whitby; Robert Newton
Journal:  Int J Cancer       Date:  2014-11-28       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.